Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

The prevalence and geographic distribution of complex co-occurring disorders: a population study.

Somers JM, Moniruzzaman A, Rezansoff SN, Brink J, Russolillo A.

Epidemiol Psychiatr Sci. 2015 May 20:1-11. [Epub ahead of print]

PMID:
25989819
2.

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R; CaRRDs Study Group.

Ann Rheum Dis. 2014 Jun;73(6):1157-62. doi: 10.1136/annrheumdis-2012-202812. Epub 2013 Jun 14.

3.

Improving the use of direct oral anticoagulants in atrial fibrillation.

Di Minno G, Russolillo A, Gambacorta C, Di Minno A, Prisco D.

Eur J Intern Med. 2013 Jun;24(4):288-94. doi: 10.1016/j.ejim.2013.01.021. Epub 2013 Apr 8. Review.

PMID:
23579170
4.

Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.

Di Minno MN, Russolillo A, Di Minno A, Camera M, Parolari A, Tremoli E.

Expert Opin Emerg Drugs. 2013 Mar;18(1):9-23. doi: 10.1517/14728214.2013.777427. Review.

PMID:
23448155
5.

[New oral anticoagulants: recommendations, precautions and perspectives for use].

Di Minno G, Russolillo A, Ventre I, Di Minno A, Prisco D.

G Ital Cardiol (Rome). 2012 Nov;13(11 Suppl 1):28S-37S. doi: 10.1714/1179.13064. Italian.

PMID:
23160017
6.

Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study.

Di Minno MN, Dentali F, Veglia F, Russolillo A, Tremoli E, Ageno W.

Thromb Haemost. 2013 Jan;109(1):167-9. doi: 10.1160/TH12-09-0663. Epub 2012 Nov 29. No abstract available.

PMID:
23196409
7.

Stroke prevention: from available antiplatelet drugs to novel molecular targets.

Di Minno MN, Momi S, Di Minno A, Russolillo A.

Curr Drug Targets. 2013 Jan 1;14(1):3-12. Review.

PMID:
23170792
8.

Ropivacaine infusion in diabetics subject with peripheral arterial disease. A prospective study.

Di Minno MN, Milone M, Russolillo A, Lupoli R, Di Minno A, Maietta P, Iacovazzo C, Salvatore G, Milone F.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):91-3. doi: 10.1055/s-0032-1327757. Epub 2012 Nov 12.

PMID:
23147211
9.

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.

Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G.

World J Gastroenterol. 2012 Nov 7;18(41):5839-47. doi: 10.3748/wjg.v18.i41.5839. Review.

10.

Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study.

Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Tarantino G, Scarpa R.

Arthritis Res Ther. 2012 Oct 4;14(5):R211. doi: 10.1186/ar4049.

11.

Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management.

Russolillo A, Iervolino S, Peluso R, Lupoli R, Di Minno A, Pappone N, Di Minno MN.

Rheumatology (Oxford). 2013 Jan;52(1):62-7. doi: 10.1093/rheumatology/kes242. Epub 2012 Sep 18. Review.

12.

Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis.

di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):141-7. doi: 10.1002/acr.21711.

PMID:
22514189
13.

Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers.

Di Minno MN, Iervolino S, Peluso R, Russolillo A, Lupoli R, Scarpa R, Di Minno G, Tarantino G; CaRRDS Study Group.

J Rheumatol. 2012 May;39(5):1042-6. doi: 10.3899/jrheum.111391. Epub 2012 Mar 15.

PMID:
22422493
14.

Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.

Di Minno MN, Iervolino S, Lupoli R, Russolillo A, Coppola A, Peluso R, Scarpa R, Di Minno G.

Semin Thromb Hemost. 2012 Jul;38(5):497-505. doi: 10.1055/s-0032-1306433. Epub 2012 Mar 7. Review.

PMID:
22399309
15.

Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers.

Iervolino S, Di Minno MN, Peluso R, Lofrano M, Russolillo A, Di Minno G, Scarpa R.

J Rheumatol. 2012 Mar;39(3):568-73. doi: 10.3899/jrheum.110763. Epub 2012 Jan 15.

PMID:
22247361
16.

Alcohol dosing and the heart: updating clinical evidence.

Di Minno MN, Franchini M, Russolillo A, Lupoli R, Iervolino S, Di Minno G.

Semin Thromb Hemost. 2011 Nov;37(8):875-84. doi: 10.1055/s-0031-1297366. Epub 2011 Dec 23. Review.

PMID:
22198852
17.

Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.

Di Minno MN, Lupoli R, Palmieri NM, Russolillo A, Buonauro A, Di Minno G.

Thromb Res. 2012 Mar;129(3):341-4. doi: 10.1016/j.thromres.2011.11.020. Epub 2011 Dec 3. Review.

PMID:
22142668
18.

Filling the gap between science & clinical practice: prevention of stroke recurrence.

Russolillo A, Di Minno MN, Tufano A, Prisco D, Di Minno G.

Thromb Res. 2012 Jan;129(1):3-8. doi: 10.1016/j.thromres.2011.08.012. Epub 2011 Sep 9. Review.

PMID:
21907395
19.

Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis.

Di Minno MN, Iervolino S, Peluso R, del Puente A, Russolillo A, Coppola A, Ruosi C, Guida A, Scarpa R, Di Minno G.

Clin Rheumatol. 2011 Jul;30(7):915-9. doi: 10.1007/s10067-011-1707-4. Epub 2011 Feb 16.

PMID:
21327686
20.

New anti-thrombotic drugs for stroke prevention.

Di Minno MN, Russolillo A, Camera M, Brambilla M, De Gregorio A, Tremoli E, Di Minno G.

Curr Vasc Pharmacol. 2011 Nov;9(6):723-32. Review.

PMID:
21143164
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk